Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Koninklijke Philips NV | 55 |
| 2 | Johnson and Johnson | 48 |
| 3 | Hisamitsu Pharmaceutical Co Inc | 44 |
| 4 | Assertio Holdings Inc | 40 |
| 5 | Biomarin Pharmaceutical Inc | 31 |
| 6 | Dr Reddys Laboratories Ltd | 27 |
| 7 | Aquestive Therapeutics Inc | 24 |
| 8 | The University of Texas System | 20 |
| 9 | GridAI Technologies Corp | 19 |
| 10 | H Lundbeck AS | 15 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 691 |
| 2 | A61P | Therapeutic activity (drug indications) | 493 |
| 3 | C07D | Heterocyclic compounds | 135 |
| 4 | A61L | Sterilising / disinfecting materials | 63 |
| 5 | G01N | Investigating / analysing materials | 60 |
| 6 | C08L | Polymer compositions (blends) | 59 |
| 7 | Y02A | Climate change adaptation | 48 |
| 8 | Y10T | Cross-reference (technical subjects) | 46 |
| 9 | A61M | Devices for introducing media into the body | 41 |
| 10 | C12N | Microorganisms, enzymes | 38 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Solubility parameter based drug delivery system and method for altering drug saturation concentration | 1997 | Hisamitsu Pharmaceutical Co Inc | 686 |
| Compositions and methods for topical administration of pharmaceutically active agents | 1998 | Hisamitsu Pharmaceutical Co Inc | 639 |
| Bioadhesive compositions and methods for topical administration of active agents | 2003 | Hisamitsu Pharmaceutical Co Inc | 505 |
| METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | 2017 | Wave Life Sciences Pte Ltd | 149 |
| Compositions and methods for topical administration of pharmaceutically active agents | 1995 | Hisamitsu Pharmaceutical Co Inc | 500 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2017 | 1 |
| 2021 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Dick de Zeeuw | University of Groningen | 9 |
| 2 | Pierre M. Laduron | Janssen (Belgium) | 9 |
| 3 | Robert F. Dannals | Johns Hopkins University | 7 |
| 4 | Michael Kassiou | Australian Nuclear Science and Technology Organisation | 7 |
| 5 | Alan A. Wilson | Johns Hopkins University | 7 |
| 6 | Henry N. Wagner | Johns Hopkins University | 6 |
| 7 | A. Wauquier | Janssen (Belgium) | 5 |
| 8 | Christian Loc’h | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | 5 |
| 9 | Hayden T. Ravert | Johns Hopkins University | 5 |
| 10 | K. Ensing | University of Groningen | 5 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Muscarinic M2 receptors in bovine tracheal smooth muscle: discrepancies between binding and function | 1988 | 156 | Ion channel regulation and function |
| Axoplasmic transport of muscarinic receptors | 1980 | 95 | Lipid Membrane Structure and Behavior |
| STEREOSPECIFIC IN VlTRO BINDING OF [3H]DEXETIMIDE TO BRAIN MUSCARINIC RECEPTORS | 1979 | 74 | Neuroscience and Neuropharmacology Research |
| Purification of muscarinic acetylcholine receptors by affinity chromatography. | 1983 | 68 | Receptor Mechanisms and Signaling |
| Synthesis of radiotracers for studying muscarinic cholinergic receptors in the living human brain using positron emission tomography: [11C]dexetimide and [11C]levetimide | 1988 | 60 | Neuroscience and Neuropharmacology Research |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Dexetimide?
Which companies hold the most patents related to Dexetimide?
What are the most highly-cited patents involving Dexetimide?
What research topics are most represented in the scientific literature on Dexetimide?
What are the dominant patent classification codes for Dexetimide-related inventions?